Abstract
FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) and FAME-2 trials have demonstrated the improved outcomes with fractional flow reserve (FFR)-guided percutaneous coronary interventions (PCI) and established the essential role of FFR to reduce major cardiovascular events (1,2). However, FFR adoption is not up to the mark in many centers and the data are almost non-existent regarding racial and sex disparities in FFR-guided PCI utilization. Therefore, we proposed to assess the trends of racial and sex disparities in FFR-guided PCI utilization over the 5-year period between 2010 and 2014.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
